Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PRAZIQUANTEL vs TRICLABENDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PRAZIQUANTEL vs TRICLABENDAZOLE: Safety Overview

Metric PRAZIQUANTEL TRICLABENDAZOLE
Total FAERS Reports 151 42
Deaths Reported 12 0
Death Rate 7.9% N/A
Hospitalizations 42 4
Average Patient Age 36.6 yrs 43.3 yrs
% Female Patients 42.8% 44.7%
FDA Approval Date Dec 29, 1982 Feb 13, 2019
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Discontinued Prescription